Search Results

There are 5839 results for: content related to: Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983–2009

  1. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  2. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  3. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  4. You have free access to this content
    Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 66, Issue 8, August 2014, Pages: 1152–1158, Daniel H. Solomon, Chris Tonner, Bing Lu, Seoyoung C. Kim, John Z. Ayanian, M. Alan Brookhart, Jeffrey N. Katz and Ed Yelin

    Version of Record online : 28 JUL 2014, DOI: 10.1002/acr.22286

  5. You have free access to this content
    Patients' Considerations in the Decision-Making Process of Initiating Disease-Modifying Antirheumatic Drugs

    Arthritis Care & Research

    Volume 67, Issue 7, July 2015, Pages: 956–964, Ingrid Nota, Constance H. C. Drossaert, Erik Taal and Mart A. F. J. van de Laar

    Version of Record online : 25 JUN 2015, DOI: 10.1002/acr.22531

  6. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Wanruchada Katchamart, Judith Trudeau, Veerapong Phumethum and Claire Bombardier

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD008495

  7. You have free access to this content
    Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: Twenty-four–week results of an open-label, clinical practice study

    Arthritis Care & Research

    Volume 65, Issue 3, March 2013, Pages: 362–371, Michael E. Weinblatt, Joel Kremer, John Cush, William Rigby, Lichen L. Teng, Jenny Devenport, Natasha Singh, Denise Lepley and Mark C. Genovese

    Version of Record online : 26 FEB 2013, DOI: 10.1002/acr.21847

  8. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  9. Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

    Arthritis Care & Research

    Volume 67, Issue 9, September 2015, Pages: 1210–1218, Jinoos Yazdany, Chris Tonner and Gabriela Schmajuk

    Version of Record online : 26 AUG 2015, DOI: 10.1002/acr.22580

  10. Abatacept for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Lara Maxwell and Jasvinder A Singh

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007277.pub2

  11. Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials

    Arthritis Care & Research

    Volume 67, Issue 11, November 2015, Pages: 1487–1495, Niels Graudal, Thorbjørn Hubeck-Graudal, Mikkel Faurschou, Bo Baslund and Gesche Jürgens

    Version of Record online : 27 OCT 2015, DOI: 10.1002/acr.22618

  12. You have free access to this content
    Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons

    Arthritis & Rheumatism

    Volume 62, Issue 10, October 2010, Pages: 2852–2863, Niels Graudal and Gesche Jürgens

    Version of Record online : 17 JUN 2010, DOI: 10.1002/art.27592

  13. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  14. Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?

    Internal Medicine Journal

    Volume 37, Issue 9, September 2007, Pages: 601–606, C. Y. Lu, K. M. Williams and R. O. Day

    Version of Record online : 2 JUN 2007, DOI: 10.1111/j.1445-5994.2007.01396.x

  15. You have free access to this content
    Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia

    Arthritis Care & Research

    Volume 64, Issue 11, November 2012, Pages: 1730–1738, Kristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, Daniel H. Solomon and Soko Setoguchi

    Version of Record online : 30 OCT 2012, DOI: 10.1002/acr.21807

  16. You have free access to this content
    2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 68, Issue 1, January 2016, Pages: 1–25, Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges Jr., Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta Vaysbrot, Christine McNaughton, Mikala Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James O'Dell, Charles King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara Drevlow, Seth Ginsberg, James Grober, E. William St.Clair, Elizabeth Tindall, Amy S. Miller and Timothy McAlindon

    Version of Record online : 6 NOV 2015, DOI: 10.1002/acr.22783

  17. You have free access to this content
    Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

    Arthritis & Rheumatology

    Volume 67, Issue 6, June 2015, Pages: 1474–1480, Jinoos Yazdany, R. Adams Dudley, Randi Chen, Grace A. Lin and Chien-Wen Tseng

    Version of Record online : 25 MAY 2015, DOI: 10.1002/art.39079

  18. You have free access to this content
    Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

    Arthritis Care & Research

    Volume 59, Issue 8, 15 August 2008, Pages: 1074–1081, Diane Lacaille, Daphne P. Guh, Michal Abrahamowicz, Aslam H. Anis and John M. Esdaile

    Version of Record online : 30 JUL 2008, DOI: 10.1002/art.23913

  19. You have free access to this content
    Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey

    Arthritis Care & Research

    Volume 64, Issue 2, February 2012, Pages: 184–189, Daniel H. Solomon, John Z. Ayanian, Ed Yelin, Tamara Shaykevich, M. Alan Brookhart and Jeffrey N. Katz

    Version of Record online : 25 JAN 2012, DOI: 10.1002/acr.20674

  20. Leflunomide for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Manathip Osiri, Beverley Shea, Vivian Welch, Maria E Suarez-Almazor, Vibeke Strand, Peter Tugwell and George A Wells

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD002047